Cargando…
Glutathione localisation in benign and malignant human breast lesions.
Reduced glutathione (GSH) has been demonstrated in benign and malignant human breast lesions using a newly developed histofluorescence technique. GSH was present in every lesion and in each case was localised to the epithelium. A semi-quantitative assessment revealed a moderate amount of GSH in norm...
Autores principales: | Murray, G. I., Burke, M. D., Ewen, S. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002032/ https://www.ncbi.nlm.nih.gov/pubmed/3620301 |
Ejemplares similares
-
Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002) -
Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
por: Luqmani, Y. A., et al.
Publicado: (1993) -
Expression of tropomyosin isoforms in benign and malignant human breast lesions.
por: Franzén, B., et al.
Publicado: (1996) -
Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue
por: Bründl, Johannes, et al.
Publicado: (2018) -
Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.
por: Hurkadli, K. S., et al.
Publicado: (1990)